Phase II trial of irinotecan, carboplatin, and bevacizumab in patients with extensive-stage small cell lung cancer

被引：0
|
作者：
Spigel, D. R.
Hainsworth, J. D.
Yardley, D. A.
Burris, H. A., III
Farley, C.
Zubkus, J.
Meng, C.
Murphy, P.
Saez, R.
Greco, F. A.
机构：
[1] Sarah Cannon Res Inst Tennessee Oncol, Nashville, TN USA
[2] Watson Clin Ctr Res, Lakeland, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
18130
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase II trial of Sorafenib in conjunction with chemotherapy and as maintenance therapy in extensive-stage small cell lung cancer
    Neelesh Sharma
    Nathan Pennell
    Myles Nickolich
    Balazs Halmos
    Patrick Ma
    Tarek Mekhail
    Pingfu Fu
    Afshin Dowlati
    Investigational New Drugs, 2014, 32 : 362 - 368
  • [32] Phase II study of irinotecan plus cisplatin followed by amrubicin in patients with extensive-stage small-cell lung cancer (WJTOG 0301)
    Iwamoto, Y.
    Kobayashi, M.
    Matsui, K.
    Yamamoto, H.
    Yamazaki, K.
    Saka, H.
    Sawa, T.
    Shibata, K.
    Takeda, K.
    Nakagawa, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [33] PHASE II STUDY OF IRINOTECAN PLUS CISPLATIN FOLLOWED BY AMRUBICIN IN PATIENTS WITH EXTENSIVE-STAGE SMALL-CELL LUNG CANCER (WJTOG 0301)
    Iwamoto, Y.
    Kobayashi, M.
    Matsui, K.
    Yamamoto, H.
    Yamazaki, K.
    Saka, H.
    Sawa, T.
    Shibata, K.
    Takeda, K.
    Nakagawa, K.
    ANNALS OF ONCOLOGY, 2008, 19 : 117 - 117
  • [34] Phase II trial of Sorafenib in conjunction with chemotherapy and as maintenance therapy in extensive-stage small cell lung cancer
    Sharma, Neelesh
    Pennell, Nathan
    Nickolich, Myles
    Halmos, Balazs
    Ma, Patrick
    Mekhail, Tarek
    Fu, Pingfu
    Dowlati, Afshin
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (02) : 362 - 368
  • [35] Cisplatin Combined with Irinotecan or Etoposide for Untreated Extensive-Stage Small Cell Lung Cancer
    Shi, Yuankai
    Hu, Xingsheng
    Hu, Yi
    Han, Xiaohong
    Li, Xue
    Lin, Lin
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S625 - S625
  • [36] Phase II Trial of Imatinib Maintenance Therapy After Irinotecan and Cisplatin in Patients With c-Kit-Positive, Extensive-Stage Small-Cell Lung Cancer
    Schneider, Bryan J.
    Kalemkerian, Gregory P.
    Ramnath, Nithya
    Kraut, Michael J.
    Wozniak, Antoinette J.
    Worden, Francis P.
    Ruckdeschel, John C.
    Zhang, Xiaohui
    Chen, Wei
    Gadgeel, Shirish M.
    CLINICAL LUNG CANCER, 2010, 11 (04) : 223 - 227
  • [37] Irinotecan plus carboplatin versus etoposide plus carboplatin in extensive disease small cell lung cancer: A randomized phase II trial.
    Schmittel, A
    von Weikersthal, LF
    Sebastian, M
    Link, H
    Schulze, K
    Thiel, E
    Keilhoz, U
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 632S - 632S
  • [38] Carboplatin in Combination with Bendamustine in Previously Untreated Patients with Extensive-Stage Small Cell Lung Cancer (SCLC)
    Wolf Köster
    G. Stamatis
    A. Heider
    K. Avramidis
    H. Wilke
    J.A. Koch
    M. Stahl
    Clinical Drug Investigation, 2004, 24 : 611 - 618
  • [39] A multi-institution phase II trial of irinotecan and carboplatin for extensive or relapsed small-cell lung cancer.
    Huynh, MT
    Fehrenbacher, L
    West, H
    Davies, A
    Simmons, J
    Lara, P
    Yarorkovsky, L
    Russin, M
    Gandara, D
    Lau, D
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 662S - 662S
  • [40] A phase II trial of fractionated irinotecan plus carboplatin for previously untreated extensive-disease small cell lung cancer
    Sohn, Joo Hyuk
    Choi, Hye Jin
    Chang, Joon
    Kim, Se Kyu
    Lee, Chang Geal
    Chung, Kyung Young
    Kim, Dae Joon
    Cho, Byoung Chul
    Shin, Sang Joon
    Moon, Yong Wha
    Kim, Joo-Hang
    LUNG CANCER, 2006, 54 (03) : 365 - 370
12345